
This specialty primarily targets hormonal imbalances and metabolic diseases, such as diabetes, obesity, adrenal gland disorders, and thyroid diseases. Diabetes medications include those that stimulate insulin secretion (such as sulfonylureas), increase cellular sensitivity to insulin (such as biguanides), and inhibit hepatic glycogen production. Injectable insulin and GLP-1 inhibitors, as well as DPP-4 inhibitors, are also used.
Itcan Biotech Co., Ltd. passed the ISO 9001 quality management system certification
Copyright © 2026 Itcan Biotech All Rights Reserved
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, you agree that your information will be combined with that of other users.